title: Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
authors.forename: Glenn
authors.initials: G
authors.lastname: Flux
authors.forename: Manuel
authors.initials: M
authors.lastname: Bardies
authors.forename: Carlo
authors.initials: C
authors.lastname: Chiesa
authors.forename: Myriam
authors.initials: M
authors.lastname: Monsieurs
authors.forename: Sauli
authors.initials: S
authors.lastname: Savolainen
authors.forename: Sven-Erik
authors.initials: SE
authors.lastname: Strand
authors.forename: Michael
authors.initials: M
authors.lastname: Lassmann
mesh_terms: D019797:3-Iodobenzylguanidine / Q000627:therapeutic use; D000818:Animals; D002986:Clinical Trials as Topic; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008223:Lymphoma / Q000532:radiotherapy*; D020714:Maximum Tolerated Dose; D018358:Neuroendocrine Tumors / Q000532:radiotherapy*; D010455:Peptides / Q000627:therapeutic use; D016499:Radioimmunotherapy / Q000379:methods; D011874:Radiometry / Q000379:methods*; D011878:Radiotherapy; D013964:Thyroid Neoplasms / Q000532:radiotherapy*
chemical_list: D007457:Iodine Radioisotopes; D010455:Peptides; D019797:3-Iodobenzylguanidine